Skip to main content

Day: March 2, 2022

Municipality Finance issues a GBP 40 million tap under its MTN programme

Municipality Finance PlcStock exchange release 2 March 2022 at 10:00 am (EET) Municipality Finance issues a GBP 40 million tap under its MTN programme On 3 March 2022 Municipality Finance Plc issues a new tranche in an amount of GBP 40 million to an existing series of notes issued on 19 January 2022. With the new tranche, the aggregate nominal amount of the notes is GBP 470 million. The maturity date of the notes is 19 June 2025, and the notes bear interest at fixed rate of 1.125% per annum. The new tranche is issued under MuniFin’s EUR 40 billion programme for the issuance of debt instruments. The offering circular and the supplemental offering circular are available in English on the company’s website at www.munifin.fi/investor-relations. MuniFin has applied for the new tranche to be admitted to trading on the Helsinki Stock Exchange...

Continue reading

QPR Software Oyj – Managers’ Transactions

QPR Software Oyj – Managers’ Transactions QPR SOFTWARE CORPORATION STOCK EXCHANGE RELEASE, 2 MARCH 2022 10:00 AM QPR Software Oyj – Managers’ Transactions Notification of a transaction by a related party in accordance with Article 19 of the Market Abuse Regulation. ___________________________________________________________________________ Notifiable name Plastiikkakirurgia J.Salo Oy Position: Related party (x) Legal EntityPerson in a senior position in the issuer Name: Sanna Salo Position: Other senior managementIssuer: QPR Software Oyj LEI: 7437003V4S76KM56UW70 Nature of the notification: FIRST NOTIFICATION Reference number: 10612/5/4 ___________________________________________________________________________ Date of the transaction: 2022-02-28 Marketplace: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009008668 Nature...

Continue reading

Italy and France: EIB supports strengthening of Europe’s semiconductor industry with €600 million loan to STMicroelectronics

Italy and France: EIB supports strengthening of Europe’s semiconductor industry with €600 million loan to STMicroelectronicsA loan to finance research and development (R&D) and new innovative production lines of a global semiconductor leaderThis support is in line with the policy of the European Union and its Member States to strengthen the semiconductor industry in EuropeFunding that also contributes to the strategic objectives of European technological sovereignty in the semiconductor industryParis, March 2, 2022 – The European Investment Bank (EIB) is providing significant financial support to STMicroelectronics: a €600 million loan for the semiconductor group’s research and development (R&D) and pre-industrialisation activities in Europe. The operation concerns investments in R&D activities for...

Continue reading

TAAT™ Secures Chainwide U.S. Gas Station Placement with Integrated Regional Marketing Program

Picture 1 All locations of Speedee Mart gas stations in the state of Nevada are now carrying TAAT™ Original, Smooth, and Menthol. The chain is incorporating an integrated advertising program to drive awareness of TAAT™ both inside and outside of its retail stores, which the Company anticipates can strengthen overall sales.Picture 2 TAAT™ Original, Smooth, and Menthol are shown for sale in the cigarette display of a Speedee Mart gas station in Las Vegas, Nevada near brands to include Maverick, which ranks fifth out of all tobacco cigarette brands in the United States based on market share1.Picture 3 Speedee Mart has provided a design for display advertising that is to be placed near its Nevada stores promoting TAAT™ based on its core value propositions as a zero-tobacco and zero-nicotine alternative to cigarettes.LAS VEGAS and...

Continue reading

01/2022 Green Hydrogen Systems – Annual report 2021

Company announcement 01/2022 Green Hydrogen Systems – Annual report 2021 Financial highlights 2021Revenue from customer contracts of DKK 5.2 million (guidance: around DKK 5 million) compared to DKK 9.4 million in 2020 Gross profit of DKK -17 million (guidance: around DKK -15 million) compared to DKK -4.0 million in 2020 EBITDA of DKK -149 million (guidance: DKK -145 to -155 million) compared to DKK -70 million in 2020 EBIT of DKK -163 million (guidance: DKK -160 to -170 million) compared to DKK -73 million in 2020 R&D capitalised and expensed costs of DKK 72 million (guidance: DKK 75-80 million) compared to DKK 20 million in 2020 Investments in tangible assets of DKK 145 million (guidance: DKK 135-145 million) compared to DKK 20 million in 2020Commercial highlights 2021Strong investor support in the listing of Green Hydrogen...

Continue reading

Taaleri Plc – Managers’ transactions – Oy Ramsay Invest Ab

TAALERI PLC                MANAGERS’ TRANSACTIONS        2 MARCH 2022 AT 9:45 (EET) Taaleri Plc – Managers’ transactions – Oy Ramsay Invest Ab Person subject to the notification requirement Name: Oy Ramsay Invest Ab Position: Closely associated person (X) Legal person (1): Person Discharging Managerial Responsibilities In Issuer Name: Peter Ramsay Position: Chief Executive Officer Issuer: Taaleri Oyj LEI: 743700LSJBDD7TMLAD92 Notification type: INITIAL NOTIFICATION Reference number: 10644/7/6 ____________________________________________ Transaction date: 2022-03-01 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI4000062195 Nature of the transaction: ACQUISITION Transaction details (1): Volume: 113 Unit price: 11.5 EUR (2): Volume: 113 Unit price: 11.5 EUR (3): Volume: 113 Unit price: 11.5 EUR (4): Volume: 113 Unit price:...

Continue reading

Celyad Oncology Announces Clinical Hold of CYAD-101-002 Phase 1b Trial

MONT-SAINT-GUIBERT, Belgium, March 02, 2022 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext & Nasdaq: CYAD) (the “Company”), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that on March 1, 2022, the Company was informed via e-mail communication from the U.S. Food and Drug Administration that the CYAD-101-002 (KEYNOTE-B79) Phase 1b trial has been placed on clinical hold due to insufficient information to assess risk to study subjects. As previously disclosed, on February 28, 2022, the Company announced that it was voluntarily pausing the CYAD-101-002 trial to investigate reports of two fatalities in the study. About Celyad Oncology SA Celyad Oncology SA is a clinical-stage biotechnology company focused on the discovery...

Continue reading

AB Amber Grid concluded lending and borrowing agreement with EPSO-G

The Lithuanian gas transmission system operator AB Amber Grid hereby notifies that on 1st March 2022 entered into lending and borrowing agreement (hereinafter referred to as Agreement) with EPSO-G. The Agreement sets forth the maximum lending limit for EPSO-G – Eur 40 000 000 and the lending limit for AB Amber Grid – Eur 20 000 000. Maximum maturity of the Agreement – 3 years. The Audit Committee of EPSO- G stated that main terms and conditions of the lending and borrowing are consistent with market conditions, are fair and reasonable with regard to the shareholders of AB Amber Grid.

Continue reading

Proactive news headlines including Australian Potash, Chimeric Therapeutics, Chalice Mining and Australian Gold and Copper

Sydney, March 02, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Australian Potash Ltd (ASX:APC) has outlined the business case for its shovel-ready Lake Wells Sulphate of Potash (SOP) Project, 160 kilometres from Laverton in Western Australia. Click here Chimeric Therapeutics Ltd (ASX:CHM) has opened the retail component of its rights offer, after raising about $7.37 million from the institutional component. Click here Chalice Mining Ltd (ASX:CHN, OTCQB:CGMLF) continues to hit the ground running at its flagship Julimar asset’s Gonneville Deposit, where extensional drilling has encountered more high-grade sulphide hits. Click here Australian Gold and Copper Ltd (ASX:AGC) has hit near-surface gold along the 15-kilometre...

Continue reading

Refractories Market to Hit $42.30 Billion by 2020-2027 | Refractories Industry Registering a CAGR of 3.6%

Companies covered in refractories market are Beijing Lier High Temperature Materials Co., Ltd. (China) HarbinsonWalker International (U.S.) Imerys (France) Into cast Group (Germany) Magnesite Group (Russia) Posco Chemical (South Korea) Puyang Refractories Group Co., Ltd. (China) Refratechnik (Germany) RHI Magnesita (Austria) Ruitai Materials Technology Co., Ltd. (China) Saint-Gobain (France) Sinosteel Group Corporation Limited (China) and more players profiled. Pune, India, March 02, 2022 (GLOBE NEWSWIRE) — According to a research report published by Fortune Business Insights, titled “Refractories Market Size, Share & Industry Analysis, By Form (Bricks & Shaped and Monolithics & Unshaped), By Product (Clay and Non-Clay), By Alkalinity (Acidic & Neutral and Basic), By End-Use Industry (Iron & Steel, Non-Ferrous...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.